We are live on
!
Find out more
CPX
Canaan Partners XI Portfolio holdings
AUM
$127M
1-Year Est. Return
217.49%
This Fund
S&P 500
This Quarter
Est. Return
-11.43%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$121M
(-49%)
Cap. Flow
-$93.2M
Cap. Flow
% of AUM
-73.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$90.6M |
| 2 |
Rallybio
RLYB
|
+$2.58M |
| 3 |
BRDS
Bird Global, Inc.
BRDS
|
+$20.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.26% |
| 2 | Technology | 19.74% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAWN
1
DELISTED
Day One Biopharmaceuticals
DAWN
| $54.8M | 43.06% |
2,548,403
-4,415,898
| -63% | -$90.6M |
|
2
Tyra Biosciences
TYRA
$1.91B
| $33.5M | 26.32% |
4,409,991
| – | – |
|
|
AEVA
3
Aeva Technologies
AEVA
$1.26B
| $25.1M | 19.74% |
3,697,039
| – | – |
|
|
4
Rallybio
RLYB
$84.6M
| $13.5M | 10.63% |
257,464
-43,750
| -15% | -$2.58M |
|
|
VECT
5
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $321K | 0.25% |
37,051
| – | – |
|
|
BRDS
6
DELISTED
Bird Global, Inc.
BRDS
| – | – |
-2,771
| Closed | -$20.3K |
|
Similar funds
CF
MF
SAP
S
PIP
VDC
SIM
PC
Canaan Partners XI's Q4 2022 Portfolio in Review
As of Q4 2022, Canaan Partners XI held 6 positions worth $127M, down 49% from $248M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Canaan Partners XI withdrew a net $93.2M in Q4 2022, closing 1 position and reducing 2 holdings. Its most notable exit was Bird Global, Inc., an estimated $20.3K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 86% a quarter earlier, followed by Technology and Consumer Discretionary.
- Canaan Partners XI's biggest Q4 2022 reduction was Day One Biopharmaceuticals, cutting an estimated $90.6M.
- Canaan Partners XI fully exited Bird Global, Inc. in Q4 2022, selling an estimated $20.3K.
- Canaan Partners XI's ten largest holdings make up 100% of its $127M portfolio in Q4 2022.
- Canaan Partners XI opened 0 new positions and closed 1 in Q4 2022.
- Canaan Partners XI's portfolio value fell 49% quarter-over-quarter to $127M.
Based on Canaan Partners XI's 13F filing for Q4 2022, filed 1 Feb 2023.